BullyKamp
FDA warns that this pet company’s marketing bites off more than it can chew.
In January 2013, another class-action lawsuit was filed against Pfizer regarding its marketing of Zoloft. This time, the allegation is that the drug label and marketing materials do not mention the numerous clinical trials in which Zoloft was shown to be no more effective in treating depression than placebo. Instead, Pfizer’s consumers are given the impression that Zoloft is very effective for treating depression. (Plumlee v. Pfizer, Inc., Case No. 13-cv-00414, N.D. Cal.)
FDA warns that this pet company’s marketing bites off more than it can chew.
TINA.org joins coalition of consumer organizations in support of the proposed rule
Company distances itself from touted “studies” while continuing to use deceptive health claims.
Can you earn a salary just by placing a small sticker on your car?
Lawsuits accuse companies of using deceptive claims to reel in consumers.